Form: 10-K

Annual report [Section 13 and 15(d), not S-K Item 405]

June 18, 2026


Exhibit 21.1
 
Grace Therapeutics, Inc.
LIST OF SUBSIDIARY
 
Name
Jurisdiction of Incorporation
Percent Owned
Grace Therapeutics U.S., Inc. (formerly Acasti Pharma U.S., Inc.)
Delaware, United States
100%